NOVARTIS FDA Approval NDA 050555

NDA 050555

NOVARTIS

FDA Drug Application

Application #050555

Documents

Letter2003-03-26
Letter2003-03-26
Letter2004-07-21
Label2003-03-26
Letter2003-03-26
Letter2004-07-21
Label2003-03-26
Label2003-03-26
Label2004-07-21
Label2004-07-21
Letter2020-04-27
Label2020-04-28
Letter2021-05-17
Label2021-05-17

Application Sponsors

NDA 050555NOVARTIS

Marketing Status

Prescription001

Application Products

001OINTMENT;OPHTHALMIC0.3%1TOBREXTOBRAMYCIN

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1981-11-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1992-09-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1992-02-03STANDARD
LABELING; LabelingSUPPL10AP1994-05-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1996-11-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1998-05-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1999-02-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1999-04-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1999-09-28STANDARD
LABELING; LabelingSUPPL17AP2003-03-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2003-03-18STANDARD
LABELING; LabelingSUPPL19AP2003-03-18STANDARD
LABELING; LabelingSUPPL21AP2004-07-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL22AP2004-07-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL35AP2015-09-10STANDARD
LABELING; LabelingSUPPL37AP2020-04-24STANDARD
LABELING; LabelingSUPPL38AP2021-05-14STANDARD

Submissions Property Types

SUPPL8Null0
SUPPL9Null0
SUPPL11Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL18Null0
SUPPL22Null0
SUPPL35Null0
SUPPL37Null7
SUPPL38Null15

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50555
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.